All above results demonstrated that the methylation of BRCA2 led to its diminished expression, which caused incomplete suppression of RAD51 thus elevating the expression of RAD51, and hence an unfavorable outcome of breast cancer, especially ER-positive breast cancer. The gene discussed is RAD51; the disease is breast carcinoma.